focus -WSS

focus

author：fashion 2025-08-11 11:42:48 - browse：84

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： 6 phony surgeries that take placebo to the extreme

hotspot

WSS

The Harvard botanist who searched for psychedelics in the Amazon

CVS is willing to dump 10% of its Medicare Advantage members

A solution to the after

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Free medical tuition alone isn't enough to close gaps in primary care

Hottest summer in 2,000 years puts focus on extreme heat, health

entertainment

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

The United States must get value

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

With competition flaring, obesity drug hits goal in liver disease study

In age of alternative facts, a scholarly course on calling out crap

Obesity drug from Roche shows promise in early study

BioMarin wins approval for gene therapy to treat hemophilia A

Obesity drugs seen as possible treatment for liver disease MASH

entertainment

Free medical tuition alone isn't enough to close gaps in primary care

A solution to the after

CVS is willing to dump 10% of its Medicare Advantage members

Supreme Court to hear if Covid misinformation is protected speech

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

focus

focus

hotspot

hotspot